Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1287490

registered interest
date	19/02/2021
answering body	Foreign, Commonwealth and Development Office
answering dept id	208
answering dept short name	Foreign, Commonwealth and Development Office
answering dept sort name	Foreign, Commonwealth and Development Office
hansard heading	Coronavirus: Disease Control
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, for what reason the Government has not endorsed the World Health Organisation's Solidarity Call To Action.
tabling member constituency	Norwich South
tabling member printed	Clive Lewis
uin	155233
answer	answer is ministerial correction date of answer 26/02/2021 answer text <p>While we support the overarching aims of the Call to Action, we have not endorsed it in its current form. This is because specific elements remain unclear. Signing a Global Call to Action means our obligations must be made clear so we can meet them in full.</p> answering member constituency Aldridge-Brownhills answering member printed Wendy Morton question first answered 26/02/2021 16:12:51 answering member 4358 label Biography information for Wendy Morton
tabling member	4500 label Biography information for Clive Lewis

1287491

registered interest
date	19/02/2021
answering body	Foreign, Commonwealth and Development Office
answering dept id	208
answering dept short name	Foreign, Commonwealth and Development Office
answering dept sort name	Foreign, Commonwealth and Development Office
hansard heading	Coronavirus: Disease Control
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what steps the Government is taking to use its representation on the Boards of (a) Gavi, the Vaccines Alliance and (b) the Coalition for Epidemic Preparedness Innovations to assess how those organisations can support the operation of the WHO's COVID-19 Technology Access Pool.
tabling member constituency	Norwich South
tabling member printed	Clive Lewis
uin	155234
answer	answer is ministerial correction date of answer 26/02/2021 answer text <p>Gavi, the Vaccine Alliance, and the Coalition for Epidemic Preparedness Innovations (CEPI) are co-leads of the vaccines pillar of the Access to COVID-19 Technologies (ACT) Accelerator. The ACT-Accelerator is an initiative to support collaboration and resource mobilisation in accelerating the development of, and equitable access to new COVID-19 vaccines, treatments, and tests. In its COVID-19 Technology Access Pool (C-TAP) concept note, the World Health Organisation sets out that the ACT-Accelerator is a separate but complementary initiative to C-TAP.</p> answering member constituency Aldridge-Brownhills answering member printed Wendy Morton question first answered 26/02/2021 11:46:15 answering member 4358 label Biography information for Wendy Morton
tabling member	4500 label Biography information for Clive Lewis

1287492

registered interest
date	19/02/2021
answering body	Foreign, Commonwealth and Development Office
answering dept id	208
answering dept short name	Foreign, Commonwealth and Development Office
answering dept sort name	Foreign, Commonwealth and Development Office
hansard heading	Coronavirus: Disease Control
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what further plans he has to consult on the WHO COVID-19 Technology Access Pool with (a) the pharmaceutical industry, (b) research institutions and (c) G7 members.
tabling member constituency	Norwich South
tabling member printed	Clive Lewis
uin	155235
answer	answer is ministerial correction date of answer 26/02/2021 answer text <p>Since the World Health Organisation (WHO) provided initial details on the COVID-19 technology access pool (C-TAP) in October 2020, the UK has, and will continue to engage with all interested parties. We are in ongoing discussions with the WHO as it refines both governance structures and the operating model for C-TAP, and will seek clarity on questions being posed by stakeholders.</p> answering member constituency Aldridge-Brownhills answering member printed Wendy Morton question first answered 26/02/2021 11:50:01 answering member 4358 label Biography information for Wendy Morton
tabling member	4500 label Biography information for Clive Lewis

1287493

registered interest
date	19/02/2021
answering body	Foreign, Commonwealth and Development Office
answering dept id	208
answering dept short name	Foreign, Commonwealth and Development Office
answering dept sort name	Foreign, Commonwealth and Development Office
hansard heading	Development Aid: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, how much Official Development Assistance is spent annually by the Government on advancing vaccine manufacturing capabilities in low and middle-income countries.
tabling member constituency	Norwich South
tabling member printed	Clive Lewis
uin	155236
answer	answer is ministerial correction date of answer 26/02/2021 answer text <p>The UK is one of the biggest global donors on COVID-19, and has pledged over £1 billion of UK aid to counter the health, humanitarian, and economic risks of the pandemic. To support global access to vaccines, we fund international organisations in delivering an 'end to end' approach to developing new vaccines, treatments, and tests, from research, development, and clinical trials through to supporting manufacturing scale-up and delivery. We report aid spend using standard Organisation for Economic Cooperation and Development (OECD) Development Assistance Committee codes, which do not track how much aid is spent on vaccine manufacturing specifically.</p><p>Building vaccine manufacturing capacity is a long-term, capital intensive, and high-risk endeavour. The UK is providing technical assistance to catalyse private sector and development finance investment into vaccine manufacturing in Africa, the region with the least manufacturing capacity globally. This includes engaging with the International Finance Corporation (IFC) to support business case development for their $4 billion Global Health Platform to support manufacturing of health essentials such as therapeutics, diagnostics, and vaccines.</p> answering member constituency Aldridge-Brownhills answering member printed Wendy Morton question first answered 26/02/2021 16:10:05 answering member 4358 label Biography information for Wendy Morton
tabling member	4500 label Biography information for Clive Lewis